B · Normal On November 16, US biopharmaceutical company Summit Therapeutics fell 29% before the market opened. Its lung cancer drug was rejected by the FDA. U.S. stock trends 🕐 2026-11-16 17:08 #biopharmaceutical #U.S. stock trends 🖼️ Save as Image Generate a beautiful long image to share on Moments or in group chats Generate now ⬇ Share 🔗Copy Link 📘Facebook 🐦X (Twitter) 💬WhatsApp 💼LinkedIn 👽Reddit ← Back to Telegraph
Comments